For most of history, a heart attack was a sudden crisis that medicine could only react to after the damage was done. In 1948, the U.S. Public Health Service launched a study in Framingham, Massachusetts to stop waiting for the crisis and start looking for the cause. By tracking the heart health of an entire town for decades, researchers redefined how we understand the relationship between daily habits and long-term survival.

A landmark longitudinal study of heart disease was published in the Annals of Internal Medicine.

Hypertension
In the 1940s, doctors believed blood pressure naturally increased with age and required no intervention.
Research
In 1948, the U.S. Public Health Service initiated with 5,209 healthy men and women between the ages of 30 and 62. Researchers conducted physical exams and lifestyle interviews every two years to identify patterns before symptoms ever appeared.
Findings
The study provided the first statistical proof that high cholesterol, high blood pressure, and smoking independently predicted heart disease. The data proved high blood pressure was a primary killer, leading to the first aggressive treatments for hypertension.
Risk Factors
Before this study, there was no clinical term for a risk factor. Framingham researchers introduced the concept, shifting from treating symptoms to managing statistical probabilities.
Three Generations
The study expanded to include the children of the original participants in 1971, and their grandchildren in 2002. This created a unique dataset for understanding how genetics and environment intersect over a 75-year span.
Mortality Drop
The insights from this single town, informing everything from statin use to tobacco cessation, helped drive a 70% drop in U.S. cardiovascular mortality rates since the study began.

From Brian

The Framingham Heart Study is a lesson in the power of patience and longitudinal science. While headlines can seem to reflect sudden breakthroughs, Framingham proved that data gathered over decades can drastically change the standard of care.

Because of these 5,000 volunteers, we have a map of the variables we can measure and manage. This study provided the blueprint for the preventive screenings we undergo today, from basic blood work to advanced genomic risk scoring.

Read On LinkedIn

<- Previous

[year of previous innovation]

[name of previous innovation]

Next ->

[year of next innovation]

[name of next innovation]